All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

All SEC Filings

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
02/11/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			3
02/10/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
02/10/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			4
02/10/22	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			3
02/07/22	5	Annual statement of changes in beneficial ownership of securities			2
01/28/22	4	Statement of changes in beneficial ownership of securities			2
01/28/22	4	Statement of changes in beneficial ownership of securities			2
01/28/22	4	Statement of changes in beneficial ownership of securities			2
01/28/22	4	Statement of changes in beneficial ownership of securities			2
01/27/22	8-K	Current report filing			4